Table of Contents
<< Previous Issue | Aug 2005 (Vol: 2005, Issue: 62) | Next Issue >> |
- Section: Business Commentaries
-
Biotechnology Means Hope
- Section: Company Profile
-
Arrow Therapeutics Ltd.
- Section: Deal Trackers
-
Byetta (exenatide)
- Section: Distribution & Marketing
-
Procter & Gamble to Co-Promote Novartis’ Enablex®
- Section: Features
-
Alkermes, Cephalon and Vivitrex#174;: Pioneering the Alcohol Dependence Market
-
Pfizer and Vicuron: A Taste of Things to Come?
-
The Supreme Court Changes Biotech Deal Flow
-
Therapy Focus: Acute Myeloid Leukaemia
- Section: General
-
Merck and Metabasis Target Metabolic Diseases
- Section: Licensing
-
Arrow and Novartis Agree on RSV
- Section: Mergers & Acquisitions
-
Salix to Acquire InKine in Gastrointestinal Merger
-
UK Acquisitions Hit the Headlines
- Section: Research & Development
-
GlaxoSmithKline and Vitae Sign Hypertension Collaboration